source
- Bristol Myers Squibb assesses AI spending after deploying tools to thousands of staffBristol Myers Squibb has recently provided artificial intelligence applications to a large portion of its workforce. The company is now turning its attention to measuring the cost of these tools a…
- FDA releases draft guidance to speed cell and gene therapy approvalsThe FDA announced a draft guidance aimed at helping developers bring gene therapies to patients more quickly. It encourages use of publicly available scientific data and existing platform knowledge…